{"nct_id":"NCT07095452","title":"A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant","status":"NOT_YET_RECRUITING","status_verified_date":"2025-07","start_date":"2025-11-12","start_date_type":"ESTIMATED","primary_completion_date":"2042-01","primary_completion_date_type":"ESTIMATED","completion_date":"2042-01","completion_date_type":"ESTIMATED","phases":["PHASE2","PHASE3"],"tickers":["ABBV"]}